vs
HANMI FINANCIAL CORP(HAFC)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
HANMI FINANCIAL CORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍($71.2M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 29.8%,领先354.2%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 17.1%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 10.4%)
韩美金融(HANMI FINANCIAL CORP)旗下韩美银行是一家总部位于美国加利福尼亚州洛杉矶的社区银行,目前在加州、得州、伊利诺伊州、纽约州、新泽西州和弗吉尼亚州共设有35家分行与8个贷款业务办事处。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
HAFC vs RIGL — 直观对比
营收规模更大
HAFC
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出4.1%
17.1%
净利率更高
RIGL
高出354.2%
29.8%
两年增速更快
RIGL
近两年复合增速
10.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $71.2M | $69.8M |
| 净利润 | $21.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 29.8% | 33.2% |
| 净利率 | 29.8% | 384.0% |
| 营收同比 | 17.1% | 21.2% |
| 净利润同比 | 20.0% | 1769.2% |
| 每股收益(稀释后) | $0.70 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HAFC
RIGL
| Q4 25 | $71.2M | $69.8M | ||
| Q3 25 | $71.0M | $69.5M | ||
| Q2 25 | $65.2M | $101.7M | ||
| Q1 25 | $62.8M | $53.3M | ||
| Q4 24 | $60.8M | $57.6M | ||
| Q3 24 | $58.5M | $55.3M | ||
| Q2 24 | $56.7M | $36.8M | ||
| Q1 24 | $58.4M | $29.5M |
净利润
HAFC
RIGL
| Q4 25 | $21.2M | $268.1M | ||
| Q3 25 | $22.1M | $27.9M | ||
| Q2 25 | $15.1M | $59.6M | ||
| Q1 25 | $17.7M | $11.4M | ||
| Q4 24 | $17.7M | $14.3M | ||
| Q3 24 | $14.9M | $12.4M | ||
| Q2 24 | $14.5M | $-1.0M | ||
| Q1 24 | $15.2M | $-8.2M |
毛利率
HAFC
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
HAFC
RIGL
| Q4 25 | 29.8% | 33.2% | ||
| Q3 25 | 31.1% | 40.9% | ||
| Q2 25 | 23.2% | 60.1% | ||
| Q1 25 | 28.1% | 23.9% | ||
| Q4 24 | 29.1% | 28.9% | ||
| Q3 24 | 25.5% | 25.4% | ||
| Q2 24 | 25.5% | 1.2% | ||
| Q1 24 | 26.0% | -23.6% |
净利率
HAFC
RIGL
| Q4 25 | 29.8% | 384.0% | ||
| Q3 25 | 31.1% | 40.2% | ||
| Q2 25 | 23.2% | 58.6% | ||
| Q1 25 | 28.1% | 21.5% | ||
| Q4 24 | 29.1% | 24.9% | ||
| Q3 24 | 25.5% | 22.5% | ||
| Q2 24 | 25.5% | -2.8% | ||
| Q1 24 | 26.0% | -27.9% |
每股收益(稀释后)
HAFC
RIGL
| Q4 25 | $0.70 | $14.11 | ||
| Q3 25 | $0.73 | $1.46 | ||
| Q2 25 | $0.50 | $3.28 | ||
| Q1 25 | $0.58 | $0.63 | ||
| Q4 24 | $0.58 | $0.82 | ||
| Q3 24 | $0.49 | $0.70 | ||
| Q2 24 | $0.48 | $-0.06 | ||
| Q1 24 | $0.50 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $796.4M | $391.5M |
| 总资产 | $7.9B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
HAFC
RIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务
HAFC
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
HAFC
RIGL
| Q4 25 | $796.4M | $391.5M | ||
| Q3 25 | $779.5M | $117.6M | ||
| Q2 25 | $762.8M | $81.9M | ||
| Q1 25 | $751.5M | $18.6M | ||
| Q4 24 | $732.2M | $3.3M | ||
| Q3 24 | $736.7M | $-14.6M | ||
| Q2 24 | $707.1M | $-29.9M | ||
| Q1 24 | $703.1M | $-31.7M |
总资产
HAFC
RIGL
| Q4 25 | $7.9B | $513.6M | ||
| Q3 25 | $7.9B | $242.5M | ||
| Q2 25 | $7.9B | $206.7M | ||
| Q1 25 | $7.7B | $176.0M | ||
| Q4 24 | $7.7B | $164.0M | ||
| Q3 24 | $7.7B | $139.4M | ||
| Q2 24 | $7.6B | $128.4M | ||
| Q1 24 | $7.5B | $126.5M |
负债/权益比
HAFC
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $206.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $203.7M | — |
| 自由现金流率自由现金流/营收 | 286.2% | — |
| 资本支出强度资本支出/营收 | 3.2% | — |
| 现金转化率经营现金流/净利润 | 9.70× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $356.1M | — |
8季度趋势,按日历期对齐
经营现金流
HAFC
RIGL
| Q4 25 | $206.0M | $22.0M | ||
| Q3 25 | $146.9M | $24.0M | ||
| Q2 25 | $-19.0M | $30.5M | ||
| Q1 25 | $25.8M | $-893.0K | ||
| Q4 24 | $52.6M | $14.5M | ||
| Q3 24 | $6.7M | $21.7M | ||
| Q2 24 | $2.1M | $302.0K | ||
| Q1 24 | $30.0M | $-5.0M |
自由现金流
HAFC
RIGL
| Q4 25 | $203.7M | — | ||
| Q3 25 | $146.4M | — | ||
| Q2 25 | $-19.6M | — | ||
| Q1 25 | $25.6M | — | ||
| Q4 24 | $49.9M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $29.2M | — |
自由现金流率
HAFC
RIGL
| Q4 25 | 286.2% | — | ||
| Q3 25 | 206.3% | — | ||
| Q2 25 | -30.0% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 82.1% | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 50.0% | — |
资本支出强度
HAFC
RIGL
| Q4 25 | 3.2% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.4% | — |
现金转化率
HAFC
RIGL
| Q4 25 | 9.70× | 0.08× | ||
| Q3 25 | 6.66× | 0.86× | ||
| Q2 25 | -1.26× | 0.51× | ||
| Q1 25 | 1.46× | -0.08× | ||
| Q4 24 | 2.97× | 1.01× | ||
| Q3 24 | 0.45× | 1.75× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图